Literature DB >> 24943401

A simple computer program to quantify red desaturation in patients with optic neuritis.

Yehoshua Almog1, Raz Gepstein, Arie Y Nemet.   

Abstract

PURPOSE: Red desaturation is a subjective, sensitive test for patients with optic nerve disease. There is no quantitative clinical test to measure the severity of color desaturation. The current study introduces a simple PowerPoint presentation for quantification of red desaturation in patients with optic neuritis.
METHODS: A Microsoft Office PowerPoint presentation was designed. A red square is shown on each half of the screen. The degree of desaturation on one side is increased in each successive slide. The patient holds a black cardboard divider between his/her eyes, such that each eye can see one-half of the screen. The patient uses the mouse to forward through the slides, thereby gradually increasing the desaturation of the red square presented to the normal eye until it matches the color of the red square seen with the tested eye. Desaturation is graded by the number of slide changes needed until subjective equal color between the eyes is perceived. The test was presented to normal volunteers and to patients with optic neuritis. The difference in saturation levels between the right and the left eyes in patients with optic neuritis vs controls was compared.
RESULTS: A total of 83 patients were included. Patients with optic neuritis had significantly increased desaturation compared to controls (6.17 ± 3.3 vs 0.24 ± 2.8 respectively; p < 0.0001).
CONCLUSIONS: This test is easy to create and efficiently quantifies the severity of red desaturation.

Entities:  

Mesh:

Year:  2014        PMID: 24943401     DOI: 10.1007/s00417-014-2687-2

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  12 in total

1.  [The new color test].

Authors:  M P Lanthony
Journal:  Bull Soc Ophtalmol Fr       Date:  1975-02

2.  Clinical measurement of saturation discrimination.

Authors:  K E Higgins; K Knoblauch; E Thall; N J Coletta; F L Ferris; F M de Monasterio
Journal:  Appl Opt       Date:  1987-04-15       Impact factor: 1.980

3.  Colorimetry by a new principle.

Authors:  R D Gunkel; D G Cogan
Journal:  Arch Ophthalmol       Date:  1978-02

4.  Spatiotemporal contrast sensitivity and colour vision in multiple sclerosis.

Authors:  D Travis; P Thompson
Journal:  Brain       Date:  1989-04       Impact factor: 13.501

5.  The Lovibond colour vision analyser.

Authors:  S J Dain
Journal:  Mod Probl Ophthalmol       Date:  1974

6.  Sahlgren's saturation test for detecting and grading acquired dyschromatopsia.

Authors:  L Frisén; H Kalm
Journal:  Am J Ophthalmol       Date:  1981-08       Impact factor: 5.258

7.  The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1991-12

8.  Deficits in visual function after resolution of optic neuritis.

Authors:  J A Fleishman; R W Beck; O A Linares; J W Klein
Journal:  Ophthalmology       Date:  1987-08       Impact factor: 12.079

9.  Acquired color vision defects in retrobulbar neuritis.

Authors:  J F Griffin; S H Wray
Journal:  Am J Ophthalmol       Date:  1978-08       Impact factor: 5.258

10.  Correlation of chromatic, spatial, and temporal sensitivity in optic nerve disease.

Authors:  S S Grigsby; A J Vingrys; S C Benes; P E King-Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-12       Impact factor: 4.799

View more
  3 in total

1.  Neuromyelitis optica spectrum disorders and anti-myelin oligodendrocyte glycoprotein positive optic neuropathies.

Authors:  Patrick Murtagh; Amy Coman; Kirk Stephenson; Maria Gaughan; David Ryan; Graeme McNeill; Christopher McGuigan; Lorraine Cassidy
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

2.  Red Desaturation Prevalence and Severity in Healthy Patients.

Authors:  Brian Mikolajczyk; Andrew Ritter; Christian Larson; John Connett; Joshua Olson; Collin McClelland; Michael S Lee
Journal:  Neurol Clin Pract       Date:  2022-02

Review 3.  Case for a new corticosteroid treatment trial in optic neuritis: review of updated evidence.

Authors:  Axel Petzold; Tasanee Braithwaite; Bob W van Oosten; Lisanne Balk; Elena H Martinez-Lapiscina; Russell Wheeler; Nils Wiegerinck; Christiaan Waters; Gordon T Plant
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-11-18       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.